Table 1.

Patients’ characteristics; Details on patients included in immunohistochemistry (A) and EIA study (B) are shown

Stage	Patients (n)
I	34
II	10
III	100
IV	3
n.a.	5
Grade
G1	37
G2	50
G3	53
n.a.	12
deaths	102
cystic lesions	21
inflammatory diseases	18
benign tumors	34
malignant tumors	38
total	111

n.a. = data on grade/FIGO stage were not available.